Chronic obstructive pulmonary disease in women: Exploring gender differences

Current Opinion in Pulmonary Medicine

Volumn 10, Issue 2, 2004, Pages 98-103

  Varkey, Anita B ^a  

^a Jr Hospital of Cook County   (United States)

Author keywords

Biomass fuels; Cigarette smoke; Indoor air pollution; Malnutrition; Poverty; Tobacco; Women

Indexed keywords

BIOFUEL; CIGARETTE SMOKE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDOOR AIR POLLUTION; MALNUTRITION; OCCUPATIONAL EXPOSURE; POVERTY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; TUBERCULOSIS;

EID: 1642569610     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200403000-00003     Document Type: Review

References (53)

1. Murray CJL, Lopez AD: Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996, 274:740-743.
2. Pauwels RA, Buist AS, Calverley PMA, et al. on behalf of the GOLD Scientific Committee. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
3. Global Strategy for the Diagnosis: Management and prevention of chronic obstructive pulmonary disease. Updated 2003. Available at: http://www. goldcopd.com/ An excellent and tremendously comprehensive review of almost all aspects of COPD.
4. http://www.nhlbi.nih.gov/heatth/public/lung/other/copd_fact.htm
5. http://www.lungusa.org/data/copd/copd1.pdf
6. Soriano JR, Maier WC, Egger P, et al.: Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000, 55:789-794.
7. Mackay J, Amos A: Women and tobacco. Respirology 2003, 8:123-130.
8. Xu X, Li B, Wang L: Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994, 7:477-483.
9. Prescott E, Bjerg AM, Andersen PK, et al.: Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1994, 10:822-827.
10. Camilli AE, Burrows B, Knudson RJ, et al.: Longitudinal changes in forced expiratory volume in one second in adults. Am Rev Respir Dis 1987, 135:794-799.
11. Peat JK, Woolcock AJ, Cullen K: Decline of lung function and development of chronic airflow limitation: a longitudinal study of smokers and non-smokers in Busselton. Western Australia. Thorax 1990, 45:32-37.
12. Anthonisen NR, Connett JE, Murray RP for the Lung Health Study Research Group. Smoking and lung function of lung health study participants after 11 years. Am J Respir Crit Care Med 2002, 166:675-679. A large clinical trial follow-up to ascertain whether differences in lung function between randomly assigned treatment groups persisted, to assess whether differences in smoking habit persist between treatment groups, and to determine whether the impact of smoking cessation on lung function decline had persisted or increased over time.
13. Dockery DW, Pope CA, Xu X, et al.: An association between air pollution and mortality in six US cities. N Engl J Med 1993, 329:1753-1759.
14. Miller FJ, Gardner DE, Graham JA, et al.: Size considerations for establishing a standard for inhalable particles. J Air Poll Control Assoc 1979, 29:610-615.
15. Smith KR: National burden of disease in India from indoor air pollution. Proc Natl Acad Sci USA 2000, 97:13286-13293.
16. Smith KR: Fuel combustion, air pollution exposure and health: the situation in developing countries. Annu Rev Energy Environ 1993, 18:529-566.
17. US National Research Council: Exposure Assessment. 1990. National Research Council; National Academy of Sciences: Washington, DC.
18. Tao X, Hong CJ, Yu S, et al.: Priority among air pollution factors for preventing chronic obstructive pulmonary disease in Shanghai. Sci Total Environ 1992, 127:57-67.
19. Pandey MR: Domestic smoke pollution and chronic bronchitis in a rural community of the Hill Region of Nepal. Thorax 1984, 39:337-339.
20. Amoli K: Bronchopulmonary disease in Iranian housewives chronically exposed to indoor smoke. Eur Respir J 1998, 11:659-663.
21. Dossing M, Khan J, al-Rabiah F: Risk factors for chronic obstructive lung disease In Saudi Arabia. Respir Med 1994, 88:519-522.
22. Perez-Padilla R, Regalado U, Vedal S, et al.: Exposure to biomass smoke and chronic airway disease in Mexican women. Am J Respir Crit Care Med 1996, 154:701-706.
23. http://w3.whosea.org/women/ch2.htm A very interesting document from the World Health Organization on the status of women in south east Asia that takes a very multidisciplinary approach to the concept of health. Chapter 2 discusses communicable diseases such as TB and HIV/AIDS, along with diseases such as viral hepatitis, malaria, and leprosy.
24. Diaz PT, Clanton TL, Pacht ER: Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med 1992, 116:124-128.
25. Gurney JW, Bates FT: Pulmonary cystic disease: comparison of pneumocystis carinii pneumatoceles and bullous emphysema due to intravenous drug abuse. Radiology 1989, 173:27-31.
26. Diaz PT, King ER, Wewers MD, et al. HIV infection increases susceptibility to smoking-induced emphysema. Chest 2000, 117(5 suppl 1):285S.
27. Diaz PT, King MA, Pacht ER, et al.: Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000, 132:369-372.
28. Snider GL, Doctor L, Demas TA, et al.: Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis 1971, 103:625-640.
29. Christian DC, Wang X: Respiratory effects of long-term cotton dust. Curr Opin Pulm Med 2003, 9:151-155. A brief but good review of byssinosis, particularly the relationship of acute airway response to chronic losses of lung function.
30. Lee P, Gildea TR, Stoller JK: Emphysema in nonsmokers: alpha 1-antitrypsin deficiency and other causes. Cleve Clin J Med 2002, 69:928-946. An easy-to-read review about the more uncommon causes and risk factors for emphysema.
31. Silverman EK, Chapman HA, Drazen JM, et al.: Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998, 157:1770-1778.
32. Sliverman EK, Weiss ST, Drazen JM, et al.: Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162:2152-2158.
33. Birring SS, Brightling CE, Bradding P, et al.: Clinical, radiological, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers. Am J Respir Crit Care Med 2002, 166:1078-1083. A well-done, 2-year prospective descriptive study that nicely reinforces epidemiologic studies that show that in nonsmokers with COPD, there is a preponderance of women and there seems to be at least two distinct pathologic subgroups.
34. Wilson DO, Rogers RM, Wright EC, et al.: Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989, 139:1435-1438.
35. http://w3.whosea.org/women/chap3_1f.htm A very interesting document from the World Health Organization on the status of women in south east Asia that takes a very multidisciplinary approach to the concept of health. This chapter examines key components of reproductive behavior that impact women's reproductive and sexual health. These include the ages at which sexual activity and reproduction begin, levels and trends in fertility over the past decades, and adolescent pregnancy and childbearing.
36. http://w3.whosea.org/women/ch7f.htm A very interesting document from the World Health Organization on the status of women in south east Asia that takes a very multidisciplinary approach to the concept of health. This chapter examines the social, economic, and political factors underlying and determining the health status of women in countries of the region. The specific focus is on the role of gender discrimination as it impacts the health of women not merely by biological factors or by factors related to individual lifestyles.
37. Chapman KR, Tashkin DP, Pye DJ: Gender bias in the diagnosis of COPD. Chest 2001, 119:1691-1695.
38. Swanney MP, Jensen RL, Crichoton DA, et al.: FEV(6) is an acceptable surrogate for FVC I the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 2000, 162:917-919.
39. Kesten S, Chapman KR: Physician perceptions and management of COPD. Chest 1993, 104:254-258.
40. Franks P, Clancy CM, Naumburg EH: Sex, access and excess. Ann Intern Med 1995, 123:548-550.
41. Ayanian JZ, Epstein AM: Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 1991, 325:221-225.
42. Gritz ER, Nielsen IR, Brooks LA: Smoking cessation and gender: the influence of physiological, psychological, and behavioral factors. J Am Med Womens Assoc 1996, 51:35-42.
43. Wetter D, Kenford S, Smith S, et al.: Gender differences in smoking. J Consult Clin Psychol 1999, 67:555-562.
44. Bjomson W, Rand C, Connett JE, et al.: Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health 1995, 85:223-230.
45. Goodman DE, Israel E, Rosenberg M, et al.: The influence of age, diagnosis and gender on proper use of metered dose inhalers. Am J Respir Crit Care Med 1994, 150:1256-1261.
46. The Lung Health Study Group: Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. Lung Health Study II. N Engl J Med 2000, 343:1902-1909.
47. Hubbard RB, Smith CHP, Smeeth L, et al.: Inhaled corticosteroids and hip fracture. Am J Respir Crit Care Med 2002, 166:1563-1566. A population-based case-control study that showed a dose-response relationship between inhaled corticosteroid use and hip fracture even after adjusting for the annual number of courses of oral corticosteroids.
48. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. Chest 1997, 11:1363-1396.
49. Lacasse Y, Wong E, Guyatt GH, et al.: Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996, 348:1115-1119.
50. Carhart RL, Ades PA: Gender differences in cardiac rehabilitation. Cardio Clin 1998, 16:37-43.
51. Deshotels A, Planchock N, Dech Z, et al.: Gender differences in perceptions of quality of life in cardiac rehabilitation patients. J Cardiopulm Rehabil 1995, 15:143-148.
52. Foy CG, Rejeski WJ, Berry MJ, et al.: Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest 2001, 119:70-76.
53. Moore SM: Women's views of cardiac rehabilitation programs. J Cardiopulm Rehabil 1996, 16:123-129.